The LMO2, BCR-ABLp190, and BCR-ABLp210 oncogenes play key roles in the onset of human acute T-lymphoblastic, pre-B acute lymphoblastic, and CML, respectively. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.